Utilizing two molecular graphs, namely the complex graph ... such as combining structure-based affinity and semantic-based drug-target prediction for more efficient drug discovery.

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

It’s not surprising that the most important drug candidates and targets are super challenging when it comes to affinity screening. Immobilization-dependent techniques like SPR, and sample-consuming ...